• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 MDA5 抗体与 COVID-19、I 型干扰素和自身免疫的关联:病例报告和系统文献回顾。

Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review.

机构信息

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy.

出版信息

Front Immunol. 2022 Jun 27;13:937667. doi: 10.3389/fimmu.2022.937667. eCollection 2022.

DOI:10.3389/fimmu.2022.937667
PMID:35833112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9271786/
Abstract

INTRODUCTION

The SARS-CoV-2 infection has been advocated as an environmental trigger for autoimmune diseases, and a paradigmatic example comes from similarities between COVID-19 and the myositis-spectrum disease associated with antibodies against the melanoma differentiation antigen 5 (MDA5) in terms of clinical features, lung involvement, and immune mechanisms, particularly type I interferons (IFN).

CASE REPORT

We report a case of anti-MDA5 syndrome with skin manifestations, constitutional symptoms, and cardiomyopathy following a proven SARS-CoV-2 infection.

SYSTEMATIC LITERATURE REVIEW

We systematically searched for publications on inflammatory myositis associated with COVID-19. We describe the main clinical, immunological, and demographic features, focusing our attention on the anti-MDA5 syndrome.

DISCUSSION

MDA5 is a pattern recognition receptor essential in the immune response against viruses and this may contribute to explain the production of anti-MDA5 antibodies in some SARS-CoV-2 infected patients. The activation of MDA5 induces the synthesis of type I IFN with an antiviral role, inversely correlated with COVID-19 severity. Conversely, elevated type I IFN levels correlate with disease activity in anti-MDA5 syndrome. While recognizing this ia broad area of uncertainty, we speculate that the strong type I IFN response observed in patients with anti-MDA5 syndrome, might harbor protective effects against viral infections, including COVID-19.

摘要

简介

SARS-CoV-2 感染被认为是自身免疫性疾病的环境触发因素,一个典范的例子来自于 COVID-19 与与黑色素瘤分化抗原 5(MDA5)抗体相关的肌炎谱疾病之间的相似性,表现在临床特征、肺部受累和免疫机制方面,特别是 I 型干扰素(IFN)。

病例报告

我们报告了一例抗 MDA5 综合征,在 SARS-CoV-2 感染后出现皮肤表现、全身症状和心肌病。

系统文献综述

我们系统地搜索了与 COVID-19 相关的炎症性肌炎的出版物。我们描述了主要的临床、免疫学和人口统计学特征,特别关注抗 MDA5 综合征。

讨论

MDA5 是一种对病毒免疫反应至关重要的模式识别受体,这可能有助于解释一些 SARS-CoV-2 感染患者产生抗 MDA5 抗体。MDA5 的激活诱导具有抗病毒作用的 I 型 IFN 的合成,与 COVID-19 的严重程度呈负相关。相反,抗 MDA5 综合征中升高的 I 型 IFN 水平与疾病活动度相关。在认识到这是一个广泛存在不确定性的领域的同时,我们推测在抗 MDA5 综合征患者中观察到的强烈的 I 型 IFN 反应可能对包括 COVID-19 在内的病毒感染具有保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e9/9271786/c703f4fc9084/fimmu-13-937667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e9/9271786/c703f4fc9084/fimmu-13-937667-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e9/9271786/c703f4fc9084/fimmu-13-937667-g001.jpg

相似文献

1
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review.抗 MDA5 抗体与 COVID-19、I 型干扰素和自身免疫的关联:病例报告和系统文献回顾。
Front Immunol. 2022 Jun 27;13:937667. doi: 10.3389/fimmu.2022.937667. eCollection 2022.
2
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C).MDA5 自身免疫与 COVID-19 大流行同期出现的间质性肺炎(MIP-C)。
EBioMedicine. 2024 Jun;104:105136. doi: 10.1016/j.ebiom.2024.105136. Epub 2024 May 8.
3
MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C).与新冠疫情同期发生的MDA5自身免疫性疾病和间质性肺炎(MIP-C)
medRxiv. 2023 Nov 5:2023.11.03.23297727. doi: 10.1101/2023.11.03.23297727.
4
SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination.SARS-CoV-2 Nsp8 通过抑制 TRIM4 介导的 K63 链接多泛素化来抑制 MDA5 抗病毒免疫反应。
PLoS Pathog. 2023 Nov 13;19(11):e1011792. doi: 10.1371/journal.ppat.1011792. eCollection 2023 Nov.
5
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.COVID-19 疫苗接种后抗 MDA5 皮肌炎:基于病例的综述。
Rheumatol Int. 2022 Sep;42(9):1629-1641. doi: 10.1007/s00296-022-05149-6. Epub 2022 Jun 4.
6
The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients.抗 MDA5 抗体阳性皮肌炎患者 1 型 IFN 与血管病变的关系。
Rheumatology (Oxford). 2019 May 1;58(5):786-791. doi: 10.1093/rheumatology/key386.
7
The RNA sensor MDA5 detects SARS-CoV-2 infection.RNA 传感器 MDA5 可检测 SARS-CoV-2 感染。
Sci Rep. 2021 Jul 1;11(1):13638. doi: 10.1038/s41598-021-92940-3.
8
Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection.冠状病毒非结构蛋白 3 与黑色素瘤分化相关基因 5 的直接相互作用调节冠状病毒感染期间的 I 型干扰素反应。
Int J Mol Sci. 2022 Oct 2;23(19):11692. doi: 10.3390/ijms231911692.
9
Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study.抗 MDA5 抗体的存在及其对 COVID-19 患者临床评估的价值:一项回顾性队列研究。
Front Immunol. 2021 Dec 20;12:791348. doi: 10.3389/fimmu.2021.791348. eCollection 2021.
10
The intersection molecule MDA5 in Cancer and COVID-19.癌症和 COVID-19 中的交叉分子 MDA5。
Front Immunol. 2022 Aug 31;13:963051. doi: 10.3389/fimmu.2022.963051. eCollection 2022.

引用本文的文献

1
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study.中国奥密克戎毒株流行期间特发性炎性肌病患者的新冠病毒病结局:一项纵向观察性研究
PLoS One. 2025 Feb 10;20(2):e0317319. doi: 10.1371/journal.pone.0317319. eCollection 2025.
2
Monocyte-macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti-melanoma differentiation-associated gene 5-positive dermatomyositis-related interstitial lung disease.单核细胞-巨噬细胞动态变化是重度抗黑色素瘤分化相关基因5阳性皮肌炎相关间质性肺病中不同肺部和外周免疫反应的关键因素。
Clin Transl Med. 2025 Feb;15(2):e70226. doi: 10.1002/ctm2.70226.
3

本文引用的文献

1
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.抗 MDA5 抗体阳性皮肌炎患者 B 细胞来源的单克隆抗体直接刺激干扰素 γ 的产生。
J Autoimmun. 2022 Jun;130:102831. doi: 10.1016/j.jaut.2022.102831. Epub 2022 Apr 15.
2
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues.恒河猴轻度感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与组织中抗原特异性T细胞反应之前的病毒控制有关。
Sci Immunol. 2022 Mar 10:eabo0535. doi: 10.1126/sciimmunol.abo0535.
3
Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection.
Exploring the Contrasts and Similarities of Dengue and SARS-CoV-2 Infections During the COVID-19 Era.
探讨 COVID-19 时代登革热和 SARS-CoV-2 感染的差异与相似之处。
Int J Mol Sci. 2024 Oct 29;25(21):11624. doi: 10.3390/ijms252111624.
4
Comprehensive Enteroviral Serology Links Infection and Anti-Melanoma Differentiation-Associated Protein 5 Dermatomyositis.全面的肠道病毒血清学研究揭示感染与抗黑色素瘤分化相关蛋白5皮肌炎之间的联系。
ACR Open Rheumatol. 2025 Jan;7(1):e11752. doi: 10.1002/acr2.11752. Epub 2024 Nov 7.
5
A Child with COVID-19 Complicated by Rapidly Progressive Severe Organizing Pneumonia: A Case Report.儿童 COVID-19 合并快速进展性严重机化性肺炎:病例报告。
Hawaii J Health Soc Welf. 2024 Oct;83(10):274-278. doi: 10.62547/XGJS9690.
6
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports.抗 MDA5 自身抗体预测 SARS-CoV-2 mRNA 疫苗接种后皮肌炎的临床动态:病例报告的回顾性统计分析。
Rheumatol Int. 2024 Oct;44(10):2185-2196. doi: 10.1007/s00296-024-05683-5. Epub 2024 Aug 27.
7
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress.抗 MDA5 抗体阳性皮肌炎:发病机制与临床进展。
Nat Rev Rheumatol. 2024 Jan;20(1):48-62. doi: 10.1038/s41584-023-01054-9. Epub 2023 Dec 6.
8
The / rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis.rs1990760 基因变异(946 位苏氨酸)区分早发性和晚发性皮肤疾病,并增加西班牙银屑病队列关节炎的风险。
Int J Mol Sci. 2023 Sep 30;24(19):14803. doi: 10.3390/ijms241914803.
9
Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy.解析 COVID-19 与特发性炎性肌病之间免疫失调的相互作用。
Front Immunol. 2023 Aug 10;14:1197493. doi: 10.3389/fimmu.2023.1197493. eCollection 2023.
10
Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity.霉酚酸酯在自身免疫性疾病治疗中的应用前景
Clin Rev Allergy Immunol. 2023 Aug;65(1):86-100. doi: 10.1007/s12016-023-08963-3. Epub 2023 Jun 20.
骨骼肌与新冠病毒:系统综述 SARS-CoV-2 感染相关性横纹肌溶解和肌炎。
Clin Exp Rheumatol. 2022 Feb;40(2):329-338. doi: 10.55563/clinexprheumatol/mkfmxt. Epub 2022 Feb 25.
4
Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System.抗黑色素瘤分化相关基因5抗体阳性皮肌炎的发病机制:以I型干扰素系统为重点的简要综述
Front Med (Lausanne). 2022 Jan 24;8:833114. doi: 10.3389/fmed.2021.833114. eCollection 2021.
5
COVID-19 Disease and Dermatomyositis: A Mini-Review.COVID-19 疾病与皮肌炎:小型综述。
Front Immunol. 2022 Jan 13;12:747116. doi: 10.3389/fimmu.2021.747116. eCollection 2021.
6
Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study.抗 MDA5 抗体的存在及其对 COVID-19 患者临床评估的价值:一项回顾性队列研究。
Front Immunol. 2021 Dec 20;12:791348. doi: 10.3389/fimmu.2021.791348. eCollection 2021.
7
Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection.MDA5抗体阳性皮肌炎与新型冠状病毒肺炎感染中的巨噬细胞活化综合征
BMC Rheumatol. 2021 Dec 13;5(1):59. doi: 10.1186/s41927-021-00225-z.
8
Idiopathic inflammatory myopathies.特发性炎性肌病
Nat Rev Dis Primers. 2021 Dec 2;7(1):86. doi: 10.1038/s41572-021-00321-x.
9
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy.新型冠状病毒肺炎后出现抗NXP2抗体阳性皮肌炎,表现为I型干扰素病。
Rheumatology (Oxford). 2022 Apr 11;61(4):e90-e92. doi: 10.1093/rheumatology/keab872.
10
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.抗 MDA5 抗体相关性皮肌炎:生物临床特征、发病机制和新兴治疗方法。
Front Immunol. 2021 Oct 20;12:773352. doi: 10.3389/fimmu.2021.773352. eCollection 2021.